Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine.
Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine.
复制标题
DOI：
10.1021/acscentsci.8b00060
复制
发表时间：
2018-05-23
影响因子：
18.2
通讯作者：
Wang LX
中科院分区：
文献类型：
--
作者：
Cai H;Zhang R;Orwenyo J;Giddens J;Yang Q;LaBranche CC;Montefiori DC;Wang LX
HIV-1 envelope glycoproteins gp120 and gp41 are presented on the virus surface as a trimer of heterodimer and are the targets of broadly neutralizing antibodies (bNAbs). We describe here the synthesis and preliminary immunological evaluation of a three-component trivalent HIV-1 V3 glycopeptide immunogen aiming to raise glycopeptide epitope-specific antibodies. Click chemistry confers efficient synthesis of the lipopeptide–glycopeptide conjugate that carries three copies of HIV-1 JR-FL gp120 V3 glycopeptide with a high-mannose glycan at the N332 glycosylation site. We found that the multivalent presentation substantially enhanced the immunogenicity of the V3 glycopeptide. The antisera induced by the three-component multivalent glycopeptide immunogen exhibited stronger binding to heterologous HIV-1 gp120s and the trimeric gp140s than that from the monovalent glycopeptide immunogen. The antisera generated from this preliminary rabbit immunization did not show virus neutralization activity, probably due to the lack of somatic maturation. The ability to elicit substantial glycopeptide epitope-specific antibodies by the three-component trivalent glycopeptide immunogen suggests that it could serve as a valuable vaccine component in combination with other vaccine candidates for further immunization studies. The designed trivalent immunogen showed enhanced immunogenicity over the monovalent construct to raise glycopeptide epitope-specific antibodies cross-reactive to gp120s of different HIV-1 strains.
登录
查看更多内容
影响因子：
16.8
作者：
Kong, Leopold;Lee, Jeong Hyun;Doores, Katie J.;Murin, Charles D.;Julien, Jean-Philippe;McBride, Ryan;Liu, Yan;Marozsan, Andre;Cupo, Albert;Klasse, Per-Johan;Hoffenberg, Simon;Caulfield, Michael;King, C. Richter;Hua, Yuanzi;Le, Khoa M.;Khayat, Reza;Deller, Marc C.;Clayton, Thomas;Tien, Henry;Feizi, Ten;Sanders, Rogier W.;Paulson, James C.;Moore, John P.;Stanfield, Robyn L.;Burton, Dennis R.;Ward, Andrew B.;Wilson, Ian A.
通讯作者：
Wilson, Ian A.
针对疫苗设计中的艾滋病毒聚糖的最新策略。
影响因子：
14.8
作者：
Horiya, Satoru;MacPherson, Iain S.;Krauss, Isaac J.
通讯作者：
Krauss, Isaac J.
影响因子：
4.9
作者：
Cai, Hui;Orwenyo, Jared;Wang, Lai-Xi
通讯作者：
Wang, Lai-Xi
影响因子：
2.2
作者：
Sarzotti-Kelsoe, Marcella;Bailer, Robert T.;Turk, Ellen;Lin, Chen-li;Bilska, Miroslawa;Greene, Kelli M.;Gao, Hongmei;Todd, Christopher A.;Ozaki, Daniel A.;Seaman, Michael S.;Mascola, John R.;Montefiori, David C.
通讯作者：
Montefiori, David C.
影响因子：
64.8
作者：
Huang J;Ofek G;Laub L;Louder MK;Doria-Rose NA;Longo NS;Imamichi H;Bailer RT;Chakrabarti B;Sharma SK;Alam SM;Wang T;Yang Y;Zhang B;Migueles SA;Wyatt R;Haynes BF;Kwong PD;Mascola JR;Connors M
通讯作者：
Connors M